Real time assessment of MS patients using a mobile application using Artificial Intelligence. MS app replace office based test. MS app can more enable regular telemedicine visits to track progress.
All
Team
Company
Patients
Physicians
Hospital
Partners
Mission
Innovation Details
Investor Info
Due Diligence Docs
Supporters
Comments
Updates
About our project
The problem we solve: More that 1M people in US
Total Lifetime Costs of MS is $4.1M per person with MS
Average Yearly Healthcare Costs for MS from $30K to $100K
About our solution:
Our AI and enabling technology will dramatically change the way that clilnical care is delivered to MS patients in the future. Clinicians that may only see a MS patients once or twice a year, through the use of the mobile app, will be able to set up monthly check-in tele-medicine calls with the patients to check their progress. The AI enabled app completely replicates the gold standard in office test with a home based app solution. The AI enabled app can help a MS patient with improvement in their neuroplasticity. The AI enabled app can predict a patient that is progressing from Mild to Moderate to Severe MS. Clinicians can use this data to prescribe different medication and treatment regimens based on this data.
Progress to
date:
$1.5M Raised to date
About Our Team
Creator: Alan Gilbert
Location: New York
Bio: Mr. Gilbert is a mission-driven Growth Serial Entrepreneur with an “up through the ranks” experience in the healthcare industry focused on the achievement of systematically improved outcomes and reduced costs across the healthcare continuum. He is involved in initiatives related to the Disruption and Positive Impact of Blockchain, Artificial Intelligence, and Machine Learning in Improved Healthcare Delivery. He is also viewed as a thought leader in the areas of Accountable Care Solutions, Value Based Care and Collaborative Care. He is a frequent contributor to professional online journals as well as a sought after speaker at industry conferences. He possesses a clear understanding of the current healthcare landscape, and has conceived and implemented strategies that resulted in new markets, new clients and increased revenue. Mr. Gilbert benefits from having a well-developed network of long-standing relationships at the executive level, with access and credibility to be viewed as their trusted advisor. Mr. Gilbert has held recent positions as the Vice President, Growth of LumiraDx and the Co-Founder and Chief Growth Officer of TEAM of Care Solutions, LLC. Mr. Gilbert was the Co-Founder of AxSys Health, the U.S. operations of a UK based Collaborative Care Technology Care Company called AxSys Technology. Mr. Gilbert has held management, administrative, technical and operational positions at large integrated academic medical centers and at large consulting firms that focus on the healthcare industry.
Specialties: Business Development
Strategic Market Planning
Market Penetration
Vertical Segmentation
Client Relationship Management
Partnership and Strategic Alliances
Strategic Consultative Selling
National and International Accounts
Vendor Management
IT Start-Ups
Managing Media Relationships
Contract Negotiations
Title: Chief Executive Officer
Advanced Degree(s): MPA
About Our Company
BeCareLink
Location: 590 Madison Avenue 9th floor B2 New York, NY 10022
What we are doing with our company is going to revolutionize the way care is delivered to MS patients.
1 - Replication of office test in home setting
2 - Having patient using app will help with patients neuro-plasticity
3 - Provider through telemedicine visits can see patients monthly virtually instead of twice a year in person
4 - Able to enhance office visits with more data on patients
5 - Using AI to predict when a MS patients is moving from Mild to Moderate to Severe MS
How We Help Physicians
What we are doing with our company is going to revolutionize the way care is delivered to MS patients.
1 - Replication of office test in home setting
2 - Having patient using app will help with patients neuro-plasticity
3 - Provider through telemedicine visits can see patients monthly virtually instead of twice a year in person
4 - Able to enhance office visits with more data on patients
5 - Using AI to predict when a MS patients is moving from Mild to Moderate to Severe MS
How We Help Hospitals
What we are doing with our company is going to revolutionize the way care is delivered to MS patients.
1 - Replication of office test in home setting
2 - Having patient using app will help with patients neuro-plasticity
3 - Provider through telemedicine visits can see patients monthly virtually instead of twice a year in person
4 - Able to enhance office visits with more data on patients
5 - Using AI to predict when a MS patients is moving from Mild to Moderate to Severe MS
How We Help Partners
What we are doing with our company is going to revolutionize the way care is delivered to MS patients.
1 - Replication of office test in home setting
2 - Having patient using app will help with patients neuro-plasticity
3 - Provider through telemedicine visits can see patients monthly virtually instead of twice a year in person
4 - Able to enhance office visits with more data on patients
5 - Using AI to predict when a MS patients is moving from Mild to Moderate to Severe MS
Challenge Mission
Affiliation(s)
Timothy Vartanian, MD, PhD - Medical Advisor, Board Member
Timothy Vartanian, MD, PhD, is a leading authority on neural regeneration and is the Director of the Judith Jaffe Center at New York-Presbyterian Hospital / Weill Cornell Medical Center.
David Putrino, PhD
Computational Neuroscience Advisor, Board Member
Dave is a physio-therapist with a PhD on neural control and reaching. At Harvard and MIT, David’s positions focused on computational neuroscience. Previously, at NYU, he concentrated on motor control and brain machine interface development research.
Key Milestones Achieved and Planned
- Finalizing MS Clinical Trial with Weill Cornell
- Starting MS Longitudinal Randomized Clinical Trial with Academic Medical Center
Our Competitive Advantages
- No other organization has replicated the "Gold Standard testing methodology" completely, while there are multiple MS apps each with a few MS tests.
- Other companies have replicated specific tests in the Gold Stand but not the entire Gold Standard
- Other competitors dont have the access to the Key Opinion Leaders in MS in the USA that we have
Barriers to Entry
- No other organization has replicated the "Gold Standard testing methodology" completely, while there are multiple MS apps each with a few MS tests.
- Other companies have replicated specific tests in the Gold Stand but not the entire Gold Standard
- Other competitors dont have the access to the Key Opinion Leaders in MS in the USA that we have
Funding, Partners and Alliances To Date
We have raised 1.5M to date in the initial seed round. We are in the process of raising $2.5M in our final seed round.
Innovation Details
Intellectual Property Summary
I have filed and have been granted a provisional patent.
Clinical Information
Finalizing results to be submitted for Publication from our Multiple Sclerosis Randomized Clinical Trial at Weill Cornell to show that our MS phone based app using AI can replace the test and the scoring of a "Gold Standard" test that is currently administered in a physicians office.
Regulatory Status
We have been advised that we will need to get a Class 1 Medical Device License when we are informing a clinician of data using our AI, Neural Network, Machine Learning algorithms.
- Funding Development of Next Version of the Mobile Platform
Thank You
What we are doing with our company is going to revolutionize the way care is delivered to MS patients.
1 - Replication of office test in home setting
2 - Having patient using app will help with patients neuro-plasticity
3 - Provider through telemedicine visits can see patients monthly virtually instead of twice a year in person
4 - Able to enhance office visits with more data on patients
5 - Using AI to predict when a MS patients is moving from Mild to Moderate to Severe MS
Investor Info
Market Size
- Getting our MS app to as many of the 400,000 MS patients in the US as possible
- Total Lifetime Costs of MS is $4.1M per person with MS
- Average Yearly Healthcare Costs for MS from $30K to $100K
- Cost of 400,000 MS patients to healthcare system is between $12B and $40B
Projected 3 Year Growth
- Cost of 400,000 MS patients to healthcare system is between $12B and $40B
- Entering into Fee For Value Programs
- 1% of Market costs impacted with cost avoidance is between $120M and $400M
- Taking 10% of avoided costs is revenue of $12M to $40M per year
Revenue Model
- Cost of 400,000 MS patients to healthcare system is between $12B and $40B
- Entering into Fee For Value Programs
- 1% of Market costs impacted with cost avoidance is between $120M and $400M
- Taking 10% of avoided costs is revenue of $12M to $40M per year
- Subsription revenue from in-app avertising within our MS app from Pharmaceutical companies
Competitors
- No other organization has replicated the "Gold Standard testing methodology" completely, while there are multiple MS apps each with a few MS tests.
- Other companies have replicated specific tests in the Gold Stand but not the entire Gold Standard
- Other competitors dont have the access to the Key Opinion Leaders in MS in the USA that we have
Traction
MS Randomized Clinical Trial being finalized and being submitted for publication from Weill Cornell
MS Longitudinal Randomized Clinical Trial starting with an academic medical center
Due Diligence Docs
Please note that access to the company's confidential materials is limited. Click this button to request access from the Company and its representatives.
Help us find best new ideas to fund by telling us what you think. Your feedback goes
straight to the team behind this project in private, so tell them what you really think.
Mr. Gilbert is a mission-driven Growth Serial Entrepreneur with an “up through the ranks” experience in the healthcare industry focused on the achievem...
Real time assessment of MS patients using a mobile application using Artificial Intelligence. MS app replace office based test. MS app can more enable regular telemedicine visits to track progress.
Thank you for visiting!
This area is for community members only. Please signin or signup and join our global community of people who care about medical innovation.
Progress to
date:
